The relevance of loci associated with blood lipids recently identiWed in European populations in individuals of African ancestry is unknown. We tested association between lipid traits and 36 previously described singlenucleotide polymorphisms (SNPs) in 1,466 individuals of African ancestry from Spanish Town, Jamaica. For the same allele and eVect direction as observed in individuals of European ancestry, SNPs at three loci (1p13, 2p21, and 19p13) showed statistically signiWcant association (p < 0.05) with LDL, two loci (11q12 and 20q13) showed association with HDL cholesterol, and two loci (11q12 and 2p24) showed association with triglycerides. The most signiWcant association was between a SNP at 1p13 and LDL cholesterol (p = 4.6 £ 10 ¡8 ). This SNP is in a linkage disequilibrium region containing four genes (CELSR2, PSRC1, MYBPHL, and SORT1) and was recently shown to relate to risk for myocardial infarction. Overall, the results of this study suggest that much of the genetic variation which inXuences blood lipids is shared across ethnic groups.
Introduction
Plasma levels of low-density lipoprotein (LDL) and highdensity lipoprotein (HDL) cholesterol are associated with cardiovascular disease. It has been estimated that over 50% of variation in LDL and HDL cholesterol levels is heritable (Kathiresan et al. 2007 ). Several of the genetic loci responsible for this heritability have been identiWed in genomewide association (GWA) studies. We and others have recently shown association between 36 loci and blood lipids, 12 of which were newly identiWed (Aulchenko et al. 2009; Kathiresan et al. 2009; Sabatti et al. 2009 ). These studies, however, were conducted in populations of European ancestry. The relevance of these Wndings to individuals of non-European ancestry remains unclear (Adeyemo and Rotimi 2010) .
Several recent studies have sought to determine whether the single-nucleotide polymorphisms (SNPs) identiWed thus far show similar association in racially diverse cohorts. Many SNPs showed association with lipids in a cross-sectional study of Malay participants in Singapore (Muallem et al. 2007; Tai et al. 2009 ). In a cohort of primarily nonHispanic blacks, Mexican Americans and non-Hispanic whites in the United States, several loci showed statistically signiWcant association (Keebler et al. 2009 ). Other reports, however, have found systematically lower eVect sizes in the risk variants discovered in European populations when they were examined in persons of African ancestry (Deo et al. 2009 ).
The purpose of this study was to attempt to replicate the previously reported genetic associations with hyperlipidemia in an African-descent population. Here, we present the results of a similar validation study in a population sample from Jamaica.
Materials and methods

Participants
Participants were recruited from Spanish Town, a stable, residential urban area neighboring the capital city of Kingston, Jamaica as part of the International Collaborative Study of Hypertension in Blacks (ICSHIB); recruitment and measurement procedures have been described in detail previously (Ataman et al. 1996; Cooper et al. 1997 ). BrieXy, a stratiWed random sampling scheme was used to recruit adult males and females aged 25-74 years from the general population; the participation rate was 60%. Spanish Town was chosen because its demographic make-up was broadly representative of Jamaica as a whole. Anthropometric and blood pressure measurements were performed by trained observers according to a standardized protocol. Serum lipid measurements were carried out on serum samples collected after an overnight fast and were performed on an Alcyon 300i autoanalyser (Abbott Laboratories, Abbott Park, IL, USA). The study protocol was reviewed and approved by the University Hospital of the West Indies/University of the West Indies/Faculty of Medical Sciences Ethics Committee, Mona, Kingston, Jamaica, and the Institutional Review Board at Loyola University Medical Center, Maywood, IL, USA. Written informed consent was obtained from all participants. Among 2,096 participants enrolled between 1993 and 1998, DNA and data from 1,466 participants were available; no other criteria (e.g. clinical or demographic) were used to select participants for the present study.
Phenotype modeling
None of the participants was taking lipid-lowering medications, so lipid values were treated as continuously distributed traits. LDL-C was calculated according to Friedewald's formula: LDL-C = total ¡ (HDL-C + 1/5TG).
If a triglyceride value was >400 mg/dL, LDL-C was treated as a missing value. Triglyceride values were log(10)-transformed. Sex-speciWc phenotype residuals were constructed after accounting for age. Each set of residuals was standardized to a mean of zero and a standard deviation of one. The standardized residual served as the phenotype in genotypephenotype association analyses. Generation of residuals was performed with the R statistical package (The R Foundation for Statistical Computing, Vienna, Austria).
SNP selection and genetic analysis
We selected 36 SNPs that exceeded genome-wide statistical signiWcance (p < 5 £ 10 ¡8 ) in three recently published GWA studies for LDL-C, HDL-C, and triglycerides (Aulchenko et al. 2009; Kathiresan et al. 2009; Sabatti et al. 2009 ). The full list of genotyped SNPs is summarized, with their associated loci in Table 2 .
Genotyping was performed with the Sequenom platform, which uses matrix-assisted laser-desorption ionization time-of-Xight mass spectrometry as described previously (Gabriel and Ziaugra 2004) .
Of the 36 genotyped SNPs, 33 met quality control standards with genotyping >90% in the samples, Hardy-Weinberg p > 1 £ 10 ¡6 for SNPs, and 1 or fewer concordance errors among replicates. Average genotyping for the 33 SNPs in the Spanish Town panel was 98.5% and concordance among replicates >99.5%.
Association testing
For each of the three traits, we used linear regression to test SNP-phenotype associations assuming an additive genetic model. These association analyses were performed in PLINK. We considered p < 0.05 to be the threshold for statistical signiWcance. Power calculations were conducted using genetic power calculator (http://pngu.mgh.harvard. edu/»purcell/gpc/).
Results and discussion
Participant characteristics
Participant characteristics are summarized in Table 1 .
Associations of genotypes with lipid traits
In this study, we examined the associations of 33 recently discovered dyslipidemia loci in a population of African descent from Jamaica. Despite the fact that these SNPs were originally derived via genome-wide association studies in a primarily Caucasian population, a number of variants showed replicable association with lipid phenotype in this primarily African population.
Six loci showed signiWcant association with lipid traits
The genetic associations of blood lipids in the Spanish Town cohort with all tested SNPs identiWed through GWA are shown in Table 2 . Given that several index SNPs were associated with more than one lipid trait in the original studies, we evaluated a total of 36 SNP-lipid trait associations, deWning signiWcance as an unadjusted p value of less than 0.05, with eVect in the same direction as the original study.
At this threshold, seven index SNPs were signiWcant. The strongest association was between rs12740374 (at 1p13 near CELSR2/PSRC1/SORT1) and LDL-C (p = 4.6 £ 10 ¡8 ). Among the signiWcant SNPs there were no notable diVerences in eVect size. In fact, for the two loci with the best association with lipid traits (rs12740374 and rs6544713), the eVect size was nearly identical to that seen in the much larger European population in which the original GWA was conducted.
Though replication of association at these six loci suggests that the loci inXuence blood lipid phenotypes in an African-descent population, it is not necessarily the case that the remaining 27 loci do not inXuence lipid phenotypes in this population. Given the modest eVect sizes of the individual genetic variants for complex traits, the available sample sizes for many of the lipid traits were too small.
To obtain a power of 80% for a SNP with a MAF = 0.20 and p = 0.05 in 1466 individuals, the SNP must explain »0.5% of overall trait variance. For most of the GWAS SNPs studied in this report, the proportion of the variance explained by the SNP is less than 0.5%.
An alternative explanation for the null Wndings is that although the loci discovered in whites may be relevant in other ethnicities, the speciWc polymorphisms associated with lipids may diVer across ethnicities because of diVerences in linkage disequilibrium structure; African populations, from which the individuals in this study have descended, have a more complex linkage disequilibrium structure than found in European whites. A Wnal possibility to consider is that genetic variants inXuencing lipid traits in individuals of African ancestry may truly be diVerent from those observed in whites. New variant discovery through additional GWA studies in non-white populations would be necessary to uncover these variants.
Majority of SNPs showed concordant direction of eVect size
With regard to the latter, two explanations for the occurrence of null results in this study, the observation of concordant direction of eVect suggests that sample size may, in fact, be the critical factor. Of the 36 tested SNP-trait associations, eVect sizes ( ) were calculated for 35 both in Caucasian and in Jamaican populations. The number of concordant SNPs regarding eVect size and direction of eVect was 23 out of the 35 (0.74) which yields a p = 0.04 when tested against random chance (50%) using a twotailed exact binomial test. Though sample size may have limited our ability to replicate each SNP in the Jamaican cohort, the signiWcant proportion of concordant SNPs Table 1 Descriptive characteristics by sex for participants in the Spanish Town Study LDL = Total cholesterol ¡ (triglycerides £ 0.46 + HDL) Unit of LDL and HDL is mmol/l. One can multiply these values by 38.7 to convert to mg/dl Diabetes mellitus: self-report of doctor diagnosis, or fasting glucose ¸7.1 mmol/l or 2 h post-challenge glucose ¸11.1 mmol/l These participants are not signiWcantly diVerent from participants who were not genotyped in terms of age, proportion of men, BMI, total cholesterol, LDL cholesterol, and prevalence of diabetes mellitus. The genotyped participants were, however, signiWcantly diVerent (p < 0.05) from those not genotyped for HDL cholesterol (higher), triglycerides (lower), and systolic blood pressure (higher) * p < 0.001 ** p < 0.0001 suggests that these loci do inXuence lipid phenotypes in the Jamaican population.
In conclusion, we evaluated 36 SNPs in 33 loci from recent GWA studies for blood lipids in a population of individuals of African descent from Jamaica. We found that at 6 loci, the exact same SNP identiWed in whites was associated with lipids in Jamaicans. Though many of the SNPs did not replicate in this population for the reasons discussed above, the six loci that did replicate show the importance of these loci in a population of African ancestry. The importance of these studies goes beyond determining relevant genetic polymorphisms in new populations. An often-cited problem with GWAS is the failure to replicate (Hirschhorn et al. 2002) . If common diseases are associated with common risks, then replication across populations would be expected. However, if common diseases are associated with population-speciWc risks, then failure to replicate across populations would be expected. The replication of these SNPs in the Jamaican population in concordance with previous reports and the direction of eVect for the majority of the other SNPs in this study suggest that these are common risk alleles that are shared between populations.
These results further illustrate the importance of conducting functional analysis and Wne mapping of these SNPs in individuals of African ancestry in addition to the European populations in which they were Wrst described.
